NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 195 filers reported holding NEKTAR THERAPEUTICS in Q3 2016. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2 | -71.4% | 3 | 0.0% | 0.00% | – |
Q4 2022 | $7 | -99.6% | 3 | -97.1% | 0.00% | – |
Q3 2020 | $2,000 | -96.9% | 103 | -97.2% | 0.00% | -100.0% |
Q1 2020 | $65,000 | +38.3% | 3,652 | +70.8% | 0.00% | +100.0% |
Q4 2019 | $47,000 | +840.0% | 2,138 | +1325.3% | 0.00% | – |
Q3 2019 | $5,000 | 0.0% | 150 | 0.0% | 0.00% | – |
Q2 2019 | $5,000 | -58.3% | 150 | -57.1% | 0.00% | -100.0% |
Q1 2019 | $12,000 | +50.0% | 350 | +40.0% | 0.00% | 0.0% |
Q4 2018 | $8,000 | -85.2% | 250 | -72.0% | 0.00% | -75.0% |
Q3 2018 | $54,000 | +20.0% | 894 | 0.0% | 0.00% | +33.3% |
Q2 2018 | $45,000 | +800.0% | 894 | +1688.0% | 0.00% | – |
Q1 2018 | $5,000 | -16.7% | 50 | -50.0% | 0.00% | -100.0% |
Q4 2017 | $6,000 | -14.3% | 100 | -75.0% | 0.00% | 0.0% |
Q3 2016 | $7,000 | +16.7% | 400 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $6,000 | +200.0% | 400 | +100.0% | 0.00% | 0.0% |
Q3 2015 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $2,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 1,828,400 | $89,281,000 | 6.61% |
Cormorant Asset Management, LP | 1,500,000 | $73,245,000 | 5.42% |
Camber Capital Management LP | 2,000,000 | $97,660,000 | 3.76% |
Rhenman & Partners Asset Management AB | 617,652 | $30,160,000 | 3.09% |
BRIDGER MANAGEMENT, LLC | 1,134,414 | $55,393,000 | 3.00% |
First Light Asset Management, LLC | 374,251 | $18,275,000 | 2.84% |
Gs Investments, Inc. | 54,000 | $2,636,820,000 | 1.97% |
SABBY MANAGEMENT, LLC | 241,922 | $11,813,000 | 1.82% |
QUANTRES ASSET MANAGEMENT Ltd | 50,000 | $2,441,000 | 1.41% |
Tibra Equities Europe Ltd | 173,183 | $8,457,000 | 1.27% |